Jeffrey Meckler
Chief Executive Officer presso INDAPTUS THERAPEUTICS, INC.
Patrimonio netto: 743 233 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Walt Linscott | M | 63 | 6 anni | |
| Michael Newman | M | 68 | 3 anni | |
| Eric Dube | M | 51 | 5 anni | |
| Gary Lyons | M | 73 | 10 anni | |
| Nir Sassi | M | 48 | 3 anni | |
| Chris Cline | M | 40 | 10 anni | |
| Elizabeth Reed | F | 53 | 7 anni | |
| Sandra Calvin | F | 59 | 10 anni | |
| Mark Gilbert | M | 63 | 3 anni | |
| Sandra E. Poole | F | 60 | 5 anni | |
| William Hayes | M | 58 | 3 anni | |
| Roger Pomerantz | M | 67 | 3 anni | |
| Anthony Maddaluna | M | 71 | 3 anni | |
| Hila Karah | F | 55 | 3 anni | |
| John Orwin | M | 59 | 7 anni | |
| Tim Coughlin | M | 57 | 9 anni | |
| Suzanne Bruhn | M | 60 | 4 anni | |
| Roy Baynes | M | 69 | 8 anni | |
| Ruth Williams-Brinkley | F | 72 | 3 anni | |
| Ron Squarer | M | 57 | 7 anni | |
| Naomi Eichenbaum | F | - | - | |
| Casey H. Logan | M | 52 | 6 anni | |
| Regina Meredith-Carpeni | F | - |
Children of Bellevue, Inc.
 Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | - |
| Roger Waltzman | M | 56 | 1 anni | |
| Greg J. Osborn | M | 58 |
Children of Bellevue, Inc.
Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | - |
| Robert E. Martell | M | 61 | 1 anni | |
| Peter Heerma | M | 53 | 5 anni | |
| Bill Rote | M | 61 | 7 anni | |
| Jula Inrig | M | 49 | 2 anni | |
| Angela Giannantonio | F | - | - | |
| Charlotte Smith | F | - | - | |
| Nivi Nehra | F | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Kozarich | M | 74 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 5 anni |
| Stephen Aselage | M | 73 | 10 anni | |
| Steven Gary Richardson | M | 70 | 3 anni | |
| Jason Aryeh | M | 56 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Jay Kranzler | M | 66 |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | 15 anni |
| Vicente J. Anido | M | 71 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 1 anni |
| Glen Ibbott | M | 61 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 2 anni |
| Sukhi Jagpal | M | 50 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 anni |
| Laura Clague | F | 64 | 8 anni | |
| Ian John Massey | M | 73 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 anni |
| Raymond Schinazi | M | 74 | 5 anni | |
| Brian O'Callaghan | M | 54 | - | |
| R. Gendreau | M | 68 |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | 30 anni |
| Stephen Sabba | M | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| David Chazanovitz | M | 72 |
Alveolus, Inc.
 Alveolus, Inc. Medical SpecialtiesHealth Technology Alveolus, Inc. used to develop non-vascular interventional stent technology. The company was founded by Eric K. Mangiardi and Gerard A. Silvestri in 2001 and is headquartered in Charlotte, NC. | - |
| Srinivas Rao | M | 55 |
Kyalin Biosciences, Inc.
 Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kyalin Biosciences, Inc. manufactures biopharmaceutical products. The firm develops an intranasal delivery form of carbetocin, which is a synthetic version of the natural occurring peptide hormone, oxytocin, for the treatment of core deficits that characterize the autistic spectrum disorders. The company was founded by Srinivas G. Rao and is headquartered in San Diego, CA. | 2 anni |
| Bruce Carter | M | 80 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 anni |
| Cameron R. Nelson | M | 58 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 anni |
| Geoffrey F. Cox | M | 80 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Margaret E. Valeur-Jensen | M | 67 | - | |
| Marc L. Panoff | M | 53 | 1 anni | |
| Robert Lee Butchofsky | M | 62 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 anni |
| David Block | M | 64 | 5 anni | |
| John Thomas | M | 70 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Kathryn Falberg | F | 63 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 3 anni |
| C. Boyd Clarke | M | 74 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 9 anni |
| Laura M. Johnson | F | - | - | |
| Jesse Shefferman | M | 52 | 3 anni | |
| Horacio Plotkin | M | 59 | 3 anni | |
| Hoon-Mo Lee | M | 46 | - | |
| Neil McFarlane | M | 51 | 3 anni | |
| Curtis Dale | M | 67 | 2 anni | |
| Alvin Shih | M | 47 | 2 anni | |
| Ciara Kennedy | M | 52 |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | 5 anni |
| Derval O'Carroll | F | 58 | 2 anni | |
| Andrea Loewen-Rodriguez | F | 57 | 3 anni | |
| Sushanta Mallick | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Noah L. Rosenberg | M | 57 | 3 anni | |
| Daniel Petree | M | 68 |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | 7 anni |
| Amir Kalali | M | 58 |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | 7 anni |
| Douglas L. Mayers | M | 70 | 1 anni | |
| Maged Shenouda | M | 59 | - | |
| Suzanne M. Cadden | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 2 anni |
| Linda M. Lupini | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 15 anni |
| Christopher Muller | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Alexander R. Lussow | M | 62 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 anni |
| Boyan Litchev | M | - | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 61 | 77.22% |
| Canada | 19 | 24.05% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jeffrey Meckler
- Contatti personali
